<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02060175</url>
  </required_header>
  <id_info>
    <org_study_id>1-2013-0076</org_study_id>
    <nct_id>NCT02060175</nct_id>
  </id_info>
  <brief_title>Comparison of the 3-month Strut Coverage After Coronary Stenting by Optical Coherence Tomography; Cilotax and DESyne</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We will compare the stent coverage at 3 months by optical coherence tomography (OCT) between
      the Cilotax and DESyne drug-eluting stents (DES). The extent of the strut uncoverage has not
      been evaluated yet for both the Cilotax and DESyne and we first sought to decide the
      reference intervals using 40 samples (total 44 patients for each group considering 10%
      drop-out rate) as the pilot study.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Because of the problem with Cilotax stent permission
  </why_stopped>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">August 2014</completion_date>
  <primary_completion_date type="Actual">August 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stent coverage</measure>
    <time_frame>up to 3 months after stent implantation</time_frame>
    <description>The percentage of stent uncoverage measured by OCT</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Patients in the Treatment of Subjects With All-comer Who Are to Undergo PCI</condition>
  <arm_group>
    <arm_group_label>1 CILOTAX arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cilotax drug-eluting stents implantation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2 DESyne arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>DESyne drug-eluting stents implantation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cilotax drug-eluting stents implantation</intervention_name>
    <arm_group_label>1 CILOTAX arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DESyne drug-eluting stents implantation</intervention_name>
    <arm_group_label>2 DESyne arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients â‰¥ 20 years old

          -  Patients in the treatment of subjects with all-comer who are to undergo PCI

        Exclusion Criteria:

          -  Pregnant women or women with potential childbearing

          -  Life expectancy &lt; 1 year
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <removed_countries>
    <country>Korea, Republic of</country>
  </removed_countries>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 7, 2014</study_first_submitted>
  <study_first_submitted_qc>February 9, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 11, 2014</study_first_posted>
  <last_update_submitted>January 7, 2015</last_update_submitted>
  <last_update_submitted_qc>January 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 9, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Optical coherence tomography, Drug-eluting stent, Strut coverage</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

